The use of estrogen- and progestin-based preparations is fond-mental for an innumerable diconditions that characterize the different phases of a woman’s vision, from contraception to hormone replacement therapy.
The action of hormonal preparations isconditioned by the type of progesti-nic rather than the estrogen in them.
Dienogest is a fourth-generation progestin with antiproliferative and anti-inflammatory properties, so it is also widely used as monotherapy in the treatment of endometriosis.
The rationale of the course is to illustrate the various options for the use of dienogest inmonotherapy or in combination with estrogen, natural or synthetic, in different ages of women and their appropriateness, in order to offer women therapeutic and/or contraceptive options that can meet their different needs.
